Development and Implementation of Papillomavirus Prophylactic Vaccines
@article{Frazer2014DevelopmentAI, title={Development and Implementation of Papillomavirus Prophylactic Vaccines}, author={I. Frazer}, journal={The Journal of Immunology}, year={2014}, volume={192}, pages={4007 - 4011} }
Translation of basic scientific findings into practical patient outcomes is a significant exercise even when the goal is conceptually straightforward, as in the development of a vaccine for an infectious disease. Recognition of the association of cervical cancer with papillomavirus infection encouraged development of a vaccine to help with prevention of this very common cancer, causing over 250,000 deaths each year worldwide. To introduce a vaccine program, it was however necessary to develop a… CONTINUE READING
30 Citations
A novel "priming-boosting" strategy for immune interventions in cervical cancer.
- Medicine
- Molecular immunology
- 2015
- 9
Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development
- Medicine
- Expert review of clinical pharmacology
- 2020
- 1
Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology
- Biology, Medicine
- Viruses
- 2019
- 16
- PDF
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon
- Medicine
- Expert review of vaccines
- 2014
- 59
Impact of HPV vaccination on anogenital warts and respiratory papillomatosis
- Medicine
- Human vaccines & immunotherapeutics
- 2016
- 19
Fifty years of immunisation in Australia (1964–2014): The increasing opportunity to prevent diseases
- Medicine
- Journal of paediatrics and child health
- 2015
- 6
References
SHOWING 1-10 OF 60 REFERENCES
Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
- Medicine
- 2010
- 61
Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
- Medicine
- Journal of clinical pharmacy and therapeutics
- 2011
- 43
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
- Biology, Medicine
- Proceedings of the National Academy of Sciences of the United States of America
- 1995
- 663
- Highly Influential
- PDF
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.
- Medicine
- Journal of the National Cancer Institute
- 2001
- 591
- PDF
Comprehensive control of human papillomavirus infections and related diseases.
- Medicine
- Vaccine
- 2013
- 123
Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes.
- Medicine
- Vaccine
- 2013
- 109
- PDF
Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses
- Biology, Medicine
- International journal of cancer
- 2006
- 68
Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- Medicine
- Advances in therapy
- 2009
- 81